Xtalks Event Header

 

First-In-Human Studies: Science-Driven Strategies

Thursday, October 23rd, 2008 - On Demand Archive now available

    Speakers for this Event:
    • Todd Johnson, MD, Senior Vice President, Early Stage Development, MDS Pharma Services 

    • Robert F. Butz, PhD, Vice President, Medical & Scientific Affairs, Biovail 

    • Michelle L. Combs, PhD,  Vice President, Global Clinical Pharmacology, MDS Pharma Services 

    • Gaetano Morelli, MD, Senior Director, Global Medical Affairs, MDS Pharma Services 
      Sponsored by:
    MDSPharma Logo

Attend this free interactive webcast and learn about science-driven strategies for a successful First-in-Human trial including:

  • “Timing” of clinical conduct
  • Pros and cons of combined SAD/MAD designs
  • Dose proportionality assessment in the planning of studies
  • Mitigating risk
  • Regulatory aspects, challenges and expectations

Access to this event is given on the understanding that you agree to the provision of your contact information to Xtalks sponsors and partners. Only primary contact information will be shared and this information will only be shared for the purposes of providing relevant offers. This registration form is an application only. Xtalks has the right to refuse access.

Please provide your company contact information for access to the webinar.

If you require help with your registration or have any questions you may contact Xtalks at: email: register@xtalks.com; phone: 416-977-6555, x 374.

By completing this registration form, you agree that the information you have provided is true and accurate.

(note: fields with marked "*" are required)
Email: *
Phone: *
First Name: *
Surname/Last Name: *
Organization: *
Title: *
Address 1: *
Address 2:
City: *
State/Prov: *
Country:
Zip/Postal code:
How did you hear about this event?:
   
What is your primary area of interest?*
When will you start your next study?
Please share any other information about your upcoming study, if applicable:
Invite colleagues:   Enter unlimited email addresses.
Pose a question to our speaker/s: